Drug-eluting stent implantation for coronary artery disease: current stents and a comparison with bypass surgery

Epstein, 2011, Coronary revascularization trends in the United States, 2001–2008, JAMA, 305, 1769, 10.1001/jama.2011.551 Chan, 2011, Appropriateness of percutaneous coronary intervention, JAMA, 306, 53 Head, 2011, A crucial factor in shared decision making: the team approach, Lancet, 377, 1836, 10.1016/S0140-6736(11)60775-7 Taggart, 2008, Revascularization for unprotected left main stem coronary artery stenosis stenting or surgery, J Am Coll Cardiol, 51, 885, 10.1016/j.jacc.2007.09.067 Marx, 2001, Bench to bedside: the development of rapamycin and its application to stent restenosis, Circulation, 104, 852, 10.1161/01.CIR.104.8.852 Morice, 2002, A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization, N Engl J Med, 346, 1773, 10.1056/NEJMoa012843 Kastrati, 2007, Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents, N Engl J Med, 356, 1030, 10.1056/NEJMoa067484 Stettler, 2007, Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis, Lancet, 370, 937, 10.1016/S0140-6736(07)61444-5 Stone, 2007, Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents, N Engl J Med, 356, 998, 10.1056/NEJMoa067193 Grube, 2003, TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions, Circulation, 107, 38, 10.1161/01.CIR.0000047700.58683.A1 Garg, 2010, Coronary stents: current status, J Am Coll Cardiol, 56, S1, 10.1016/j.jacc.2010.06.007 Turco, 2007, Polymer-based, paclitaxel-eluting TAXUS Liberte stent in de novo lesions: the pivotal TAXUS ATLAS trial, J Am Coll Cardiol, 49, 1676, 10.1016/j.jacc.2007.01.069 Kim, 2009, A prospective, randomized, 6-month comparison of the coronary vasomotor response associated with a zotarolimus- versus a sirolimus-eluting stent: differential recovery of coronary endothelial dysfunction, J Am Coll Cardiol, 53, 1653, 10.1016/j.jacc.2009.01.051 Cook, 2007, Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation, Circulation, 115, 2426, 10.1161/CIRCULATIONAHA.106.658237 Cook, 2009, Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis, Circulation, 120, 391, 10.1161/CIRCULATIONAHA.109.854398 Serruys, 2010, Comparison of zotarolimus-eluting and everolimus-eluting coronary stents, N Engl J Med, 363, 136, 10.1056/NEJMoa1004130 Fajadet, 2006, Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial, Circulation, 114, 798, 10.1161/CIRCULATIONAHA.105.591206 Park, 2010, J Am Coll Cardiol, 56, 1187, 10.1016/j.jacc.2010.03.086 Rasmussen, 2010, Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial, Lancet, 375, 1090, 10.1016/S0140-6736(10)60208-5 Leon, 2010, A randomized comparison of the ENDEAVOR zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trial, J Am Coll Cardiol, 55, 543, 10.1016/j.jacc.2009.08.067 Serruys, 2005, A randomized comparison of a durable polymer Everolimus-eluting stent with a bare metal coronary stent: the SPIRIT first trial, EuroIntervention, 1, 58 Garg, 2011, Four-year clinical follow-up of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: the SPIRIT II trial, Catheter Cardiovasc Interv, 77, 1012, 10.1002/ccd.22770 Kedhi, 2010, Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial, Lancet, 375, 201, 10.1016/S0140-6736(09)62127-9 Stone, 2008, Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial, JAMA, 299, 1903, 10.1001/jama.299.16.1903 Stone, 2010, Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease, N Engl J Med, 362, 1663, 10.1056/NEJMoa0910496 Raber, 2011, Long-term comparison of everolimus-eluting and sirolimus-eluting stents for coronary revascularization, J Am Coll Cardiol, 57, 2143, 10.1016/j.jacc.2011.01.023 Park, 2009, Efficacy of Xience/promus versus Cypher in rEducing Late Loss after stENTing (EXCELLENT) trial: study design and rationale of a Korean multicenter prospective randomized trial, Am Heart J, 157, 811, 10.1016/j.ahj.2009.02.008 Silber, 2011, Unrestricted randomised use of two new generation drug-eluting coronary stents: 2-year patient-related versus stent-related outcomes from the RESOLUTE All Comers trial, Lancet, 377, 1241, 10.1016/S0140-6736(11)60395-4 Nakazawa, 2009, Incidence and predictors of drug-eluting stent fracture in human coronary artery a pathologic analysis, J Am Coll Cardiol, 54, 1924, 10.1016/j.jacc.2009.05.075 Alfonso, 2009, Coronary aneurysms after drug-eluting stent implantation: clinical, angiographic, and intravascular ultrasound findings, J Am Coll Cardiol, 53, 2053, 10.1016/j.jacc.2009.01.069 Aoki, 2008, Coronary artery aneurysms after drug-eluting stent implantation, JACC Cardiovasc Interv, 1, 14, 10.1016/j.jcin.2007.10.004 Nijjer, 2011, Safety of clopidogrel being continued until the time of coronary artery bypass grafting in patients with acute coronary syndrome: a meta-analysis of 34 studies, Eur Heart J, 10.1093/eurheartj/ehr151 Head, 2011, New anticoagulants in cardiac surgery, Interv Cardiol, 6, 71, 10.15420/ICR.2011.6.1.71 Held, 2011, Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial, J Am Coll Cardiol, 57, 672, 10.1016/j.jacc.2010.10.029 Hannan, 2008, Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease, N Engl J Med, 358, 331, 10.1056/NEJMoa071804 Hlatky, 2009, Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials, Lancet, 373, 1190, 10.1016/S0140-6736(09)60552-3 Hoffman, 2003, A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eight-year outcomes, J Am Coll Cardiol, 41, 1293, 10.1016/S0735-1097(03)00157-8 Task Force on Myocardial Revascularization of the European Society of C, 2010, Guidelines on myocardial revascularization, Eur J Cardiothorac Surg, 38, S1 Serruys, 2009, Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease, N Engl J Med, 360, 961, 10.1056/NEJMoa0804626 Aziz, 2007, Meta-analysis of minimally invasive internal thoracic artery bypass versus percutaneous revascularisation for isolated lesions of the left anterior descending artery, BMJ, 334, 617, 10.1136/bmj.39106.476215.BE Kapoor, 2008, Isolated disease of the proximal left anterior descending artery comparing the effectiveness of percutaneous coronary interventions and coronary artery bypass surgery, JACC Cardiovasc Interv, 1, 483, 10.1016/j.jcin.2008.07.001 Ben-Gal, 2006, Revascularization of left anterior descending artery with drug-eluting stents: comparison with minimally invasive direct coronary artery bypass surgery, Ann Thorac Surg, 82, 2067, 10.1016/j.athoracsur.2006.06.041 Garg, 2011, Five-year outcomes of percutaneous coronary intervention compared to bypass surgery in patients with multivessel disease involving the proximal left anterior descending artery: an ARTS-II sub-study, EuroIntervention, 6, 1060, 10.4244/EIJV6I9A185 Hong, 2005, Percutaneous coronary intervention with drug-eluting stent implantation vs. minimally invasive direct coronary artery bypass (MIDCAB) in patients with left anterior descending coronary artery stenosis, Catheter Cardiovasc Interv, 64, 75, 10.1002/ccd.20238 Thiele, 2009, Randomized comparison of minimally invasive direct coronary artery bypass surgery versus sirolimus-eluting stenting in isolated proximal left anterior descending coronary artery stenosis, J Am Coll Cardiol, 53, 2324, 10.1016/j.jacc.2009.03.032 Toutouzas, 2008, A preliminary experience report: drug-eluting stents versus coronary artery bypass surgery in patients with a single lesion in the proximal left anterior descending artery suffering from diabetes mellitus and chronic stable angina, Hellenic J Cardiol, 49, 65 Yan, 2009, Percutaneous treatment with drug-eluting stent vs bypass surgery in patients suffering from chronic stable angina with multivessel disease involving significant proximal stenosis in left anterior descending artery, Circ J, 73, 1848, 10.1253/circj.CJ-08-1060 Bravata, 2007, Systematic review: the comparative effectiveness of percutaneous coronary interventions and coronary artery bypass graft surgery, Ann Intern Med, 147, 703, 10.7326/0003-4819-147-10-200711200-00185 Hannan, 2005, Long-term outcomes of coronary-artery bypass grafting versus stent implantation, N Engl J Med, 352, 2174, 10.1056/NEJMoa040316 Yan, 2011, Drug-eluting stents versus coronary artery bypass grafting for the treatment of coronary artery disease: a meta-analysis of randomized and nonrandomized studies, J Thorac Cardiovasc Surg, 141, 1134, 10.1016/j.jtcvs.2010.07.001 Kappetein, 2011, Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial, Eur Heart J, 23, 2125, 10.1093/eurheartj/ehr213 Head, 2011, Nonrandomized data on drug-eluting stents compared with coronary bypass surgery caution with interpretation, J Am Coll Cardiol, 57, 2457, 10.1016/j.jacc.2011.01.028 Sianos, 2005, The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease, EuroIntervention, 1, 219 Banning, 2010, Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents, J Am Coll Cardiol, 55, 1067, 10.1016/j.jacc.2009.09.057 Roffi, 2011, Current concepts on coronary revascularization of diabetic patients, Eur Heart J, 10.1093/eurheartj/ehr305 Kapur, 2010, Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial, J Am Coll Cardiol, 55, 432, 10.1016/j.jacc.2009.10.014 Daemen, 2008, Drug-eluting stents vs. coronary-artery bypass grafting, N Engl J Med, 358, 2641, 10.1056/NEJMc080368 Lee, 2010, Meta-analysis of clinical studies comparing coronary artery bypass grafting with percutaneous coronary intervention and drug-eluting stents in patients with unprotected left main coronary artery narrowings, Am J Cardiol, 105, 1070, 10.1016/j.amjcard.2009.12.007 Zheng, 2011, Comparison between drug-eluting stents and coronary artery bypass grafting for unprotected left main coronary artery disease: a meta-analysis of two randomized trials and thirteen observational studies, Cardiology, 118, 22, 10.1159/000324169 Morice, 2010, Circulation, 121, 2645, 10.1161/CIRCULATIONAHA.109.899211 Park, 2011, Complexity of atherosclerotic coronary artery disease and long-term outcomes in patients with unprotected left main disease treated with drug-eluting stents or coronary artery bypass grafting, J Am Coll Cardiol, 57, 2152, 10.1016/j.jacc.2011.01.033 Kappetein, 2010, Editorial comment: is there enough evidence that proves clinical equipoise between stenting and coronary surgery for patients with left main coronary artery disease?, Eur J Cardiothorac Surg, 38, 428, 10.1016/j.ejcts.2010.04.014 Park, 2011, Randomized trial of stents versus bypass surgery for left main coronary artery disease, N Engl J Med, 364, 1718, 10.1056/NEJMoa1100452